The Food and Drug Administration has placed major retail chains under regulatory scrutiny following inspections at their Bonifacio Global City branches.
The inspections were led by FDA Director General Atty. Paolo Teston as part of the agency’s nationwide initiative to strengthen oversight of food and health products sold in retail stores and across distribution channels.
The retailers involved include Landers Superstore and S&R Membership Shopping.
Inspection Findings
The inspections form part of the Philippine FDA’s nationwide initiative to strengthen oversight of food and health products in the market. According to the agency, certain products lacked:
- Valid FDA product registration
• Proper labeling in accordance with regulatory standards
• Complete documentation and traceability records
Following the inspection, the FDA issued formal notices reminding retailers of their legal responsibility to ensure that all food and health products offered for sale are fully registered, properly labeled, and traceable.
Possible Regulatory Consequences
The agency warned that non-compliance may result in decisive regulatory action, including:
- Seizure of non-compliant products
• Suspension or revocation of licenses
• Closure of operations
• Administrative or legal proceedings
FDA officials emphasized that regulatory accountability extends beyond physical stores to include online distribution channels and digital marketplaces. Large retailers play a critical role in the supply chain and are expected to exercise due diligence over the products they distribute.
Strengthening Compliance Across the Supply Chain
The Philippine FDA reiterated its commitment to safeguarding public health and ensuring market integrity. Manufacturers, importers, distributors, and retailers are urged to strengthen internal compliance controls and implement structured quality risk management systems.
Organizations operating in regulated sectors typically benefit from clearly defined corrective and preventive action frameworks, inspection readiness strategies, and structured regulatory documentation processes. Strengthening compliance systems — including pharmacovigilance oversight and safety monitoring where applicable — supports regulatory alignment and minimizes enforcement exposure.
https://www.baupharma.com/services-categories/pharmacovigilance/
Sustained monitoring and enforcement activities will continue nationwide to ensure that only compliant food and health products reach consumers.
For more information: 𝐂𝐎𝐌𝐏𝐋𝐘 𝐎𝐑 𝐅𝐀𝐂𝐄 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐀𝐂𝐓𝐈𝐎𝐍 𝐅𝐃𝐀 𝐏𝐔𝐓𝐒 𝐌𝐀𝐉𝐎𝐑 𝐑𝐄𝐓𝐀𝐈𝐋𝐄𝐑𝐒 𝐎𝐍 𝐍𝐎𝐓𝐈𝐂𝐄 𝐎𝐕𝐄𝐑 𝐅𝐎𝐎𝐃 𝐀𝐍𝐃 𝐇𝐄𝐀𝐋𝐓𝐇 𝐏𝐑𝐎𝐃𝐔𝐂𝐓𝐒
